Completed OBSERVATIONAL NCT02266251

Optimizing Health Outcomes in Patients With Symptomatic Aortic Valve Disease (PCORI-AVR)

Sponsor: American College of Cardiology

Updated 7 times since 2017 Last updated: Oct 12, 2017 Started: May 31, 2014 Primary completion: Apr 30, 2017 Completion: May 30, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Aortic Valve Disease and is currently completed. American College of Cardiology leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 2 earlier versions

Oct 2017 — Apr 2018 [monthly]

Completed NA

Status: Enrolling By Invitation → Completed
Jan 2017 — Oct 2017 [monthly]

Enrolling By Invitation NA

First recorded

May 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American College of Cardiology
Duke University
Patient-Centered Outcomes Research Institute
The Society of Thoracic Surgeons

Data source: Duke University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Durham, United States